Global Pediatric Epilepsy Therapeutics Market Report By Disease Type (Benign Rolandic Epilepsy (BRE), Childhood Absence Epilepsy (CAE), Juvenile Myoclonic Epilepsy (JME), Infantile Spasms (or West syndrome), Lennox-gastaut Syndrome (LGS), Others), By Therapeutics (Anti-Epileptic Drugs, Dietary Supplements, Vagal Nerve Stimulation, Surgical Therapies, Focal Cortical Resection, Lobectomy, Corpus Callosotomy, Hemispherectomy), By End User (Hospitals, Neurology Centers, Home Care Settings, Ambulatory Surgical Centers) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214040
April 2021
Report Formats:
The global demand for Pediatric Epilepsy Therapeutics Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2021 - 2027. 

Pediatric epilepsy is the most common and challenging neurologic disorders. Various modalities exist to treat pediatric-onset seizures. It can be treated with anticonvulsant medications, a ketogenic diet, and a vagal nerve stimulator. Young infants with intractable epilepsy are candidates for surgery. Surgical procedures include removing a circumscribed portion of the temporal lobe, hemispherectomy, lobectomy corpus, and callosotomy. With a new resurgence in ubiquity and extension of signs, these treatments can prompt independence from seizures or an altogether decreased seizure trouble for some patients.

Market Dynamics
The growing frequency of epilepsy among children, rising awareness regarding treatment, and increasing approval for new drugs and devices for treatment drive the global pediatric epilepsy therapeutics market. As per the National Center for Biotechnology Information, the incidence of pediatric epilepsy ranges from 41-187 per 100,000. The higher rate is reported from rural areas of underdeveloped countries. The market is witnessing many changes in terms of treatment. There has been a wave of new approvals in recent years. Researchers are actively examining new medications and non-drug treatments for epilepsy. New types of neuromodulator devices have been approved to treat epilepsy. Despite the development of new epilepsy treatments, approximately one-third of pediatric patients with epilepsy remain medically refractory due to lack of awareness, high expenses, and fear of unacceptable side effects. Companies are engaged in tackling these challenges. Successful overcome of this will result in fruitful revenue.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of pediatric epilepsy therapeutics.

Market Segmentation

This section of the pediatric epilepsy therapeutics market report  provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.

By Disease Type
  • Benign Rolandic Epilepsy (BRE)
  • Childhood Absence Epilepsy (CAE)
  • Juvenile Myoclonic Epilepsy (JME)
  • Infantile Spasms (Or West Syndrome)
  • Lennox-Gastaut Syndrome (LGS)
  • Others
By Therapeutics
  • Anti-Epileptic Drugs
  • Dietary Supplements
  • Vagal Nerve Stimulation
  • Surgical Therapies
  • Focal Cortical Resection
  • Lobectomy
  • Corpus Callosotomy
  • Hemispherectomy
By End User
  • Hospitals
  • Neurology Centers
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Pediatric Epilepsy Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Pediatric Epilepsy Therapeutics Market Share by Region (Representative Graph)

Global Pediatric Epilepsy Therapeutics Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pediatric epilepsy therapeutics market include Abbott Laboratories, GlaxoSmithKline plc, Cephalon, Inc., Johnson & Johnson, Pfizer, Inc., Novartis AG, Sunovion Pharmaceuticals sInc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . PEDIATRIC EPILEPSY THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Disease Type
           3.7.2 By Therapeutics
           3.7.3 By End User
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL PEDIATRIC EPILEPSY THERAPEUTICS MARKET ANALYSIS BY DISEASE TYPE
       6.1 Overview by Disease Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Disease Type
       6.4 Benign Rolandic Epilepsy (BRE) Market by Regions
       6.5 Childhood Absence Epilepsy (CAE) Market by Regions
       6.6 Juvenile Myoclonic Epilepsy (JME) Market by Regions
       6.7 Infantile Spasms (Or West Syndrome) Market by Regions
       6.8 Lennox-Gastaut Syndrome (LGS) Market by Regions
       6.9 Others Market by Regions
 
7 . GLOBAL PEDIATRIC EPILEPSY THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS
       7.1 Overview by Therapeutics
       7.2 Historical and Forecast Data
       7.3 Analysis by Therapeutics
       7.4 Anti-Epileptic Drugs Market by Regions
       7.5 Dietary Supplements Market by Regions
       7.6 Vagal Nerve Stimulation Market by Regions
       7.7 Surgical Therapies Market by Regions
       7.8 Focal Cortical Resection Market by Regions
       7.9 Lobectomy Market by Regions
       7.10. Corpus Callosotomy Market by Regions
       7.11 Hemispherectomy Market by Regions
 
8 . GLOBAL PEDIATRIC EPILEPSY THERAPEUTICS MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Historical and Forecast Data
       8.3 Analysis by End User
       8.4 Hospitals Market by Regions
       8.5 Neurology Centers Market by Regions
       8.6 Home Care Settings Market by Regions
       8.7 Ambulatory Surgical Centers Market by Regions
       8.8 Regional Analysis Market by Regions
 
9 . GLOBAL PEDIATRIC EPILEPSY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE PEDIATRIC EPILEPSY THERAPEUTICS COMPANIES
       10.1. Pediatric Epilepsy Therapeutics Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF PEDIATRIC EPILEPSY THERAPEUTICS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Abbott Laboratories
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. GlaxoSmithKline plc
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Cephalon, Inc.
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Johnson & Johnson
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Pfizer, Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Novartis AG
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Sunovion Pharmaceuticals Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Valeant Pharmaceuticals International, Inc.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Sanofi S.A.
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Disease Type (USD MN)
  • Benign Rolandic Epilepsy (BRE) Market by Geography (USD MN)
  • Childhood Absence Epilepsy (CAE) Market by Geography (USD MN)
  • Juvenile Myoclonic Epilepsy (JME) Market by Geography (USD MN)
  • Infantile Spasms (Or West Syndrome) Market by Geography (USD MN)
  • Lennox-Gastaut Syndrome (LGS) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Therapeutics (USD MN)
  • Anti-Epileptic Drugs Market by Geography (USD MN)
  • Dietary Supplements Market by Geography (USD MN)
  • Vagal Nerve Stimulation Market by Geography (USD MN)
  • Surgical Therapies Market by Geography (USD MN)
  • Focal Cortical Resection Market by Geography (USD MN)
  • Lobectomy Market by Geography (USD MN)
  • Corpus Callosotomy Market by Geography (USD MN)
  • Hemispherectomy Market by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Neurology Centers Market by Geography (USD MN)
  • Home Care Settings Market by Geography (USD MN)
  • Ambulatory Surgical Centers Market by Geography (USD MN)
  • Regional Analysis Market by Geography (USD MN)
  • Global Pediatric Epilepsy Therapeutics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Pediatric Epilepsy Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Pediatric Epilepsy Therapeutics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Disease Type
  • Market Attractiveness Analysis by Therapeutics
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Disease Type (USD MN)
  • Benign Rolandic Epilepsy (BRE) Market by Geography (USD MN)
  • Childhood Absence Epilepsy (CAE) Market by Geography (USD MN)
  • Juvenile Myoclonic Epilepsy (JME) Market by Geography (USD MN)
  • Infantile Spasms (Or West Syndrome) Market by Geography (USD MN)
  • Lennox-Gastaut Syndrome (LGS) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Therapeutics (USD MN)
  • Anti-Epileptic Drugs Market by Geography (USD MN)
  • Dietary Supplements Market by Geography (USD MN)
  • Vagal Nerve Stimulation Market by Geography (USD MN)
  • Surgical Therapies Market by Geography (USD MN)
  • Focal Cortical Resection Market by Geography (USD MN)
  • Lobectomy Market by Geography (USD MN)
  • Corpus Callosotomy Market by Geography (USD MN)
  • Hemispherectomy Market by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Neurology Centers Market by Geography (USD MN)
  • Home Care Settings Market by Geography (USD MN)
  • Ambulatory Surgical Centers Market by Geography (USD MN)
  • Regional Analysis Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials